Viewing StudyNCT01687244

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 12:53 AM
Last Modification Date: 2024-10-26 @ 10:56 AM
Study NCT ID: NCT01687244
Status: COMPLETED
Last Update Posted: 2017-07-24
First Post: 2012-09-06
Brief Title: Intravesical Administration of rAd-IFNSyn3 in Patients With BCG-Refractory or Relapsed Bladder Cancer
Sponsor: FKD Therapies Oy
Organization: FKD Therapies Oy
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Superficial Bladder Cancer
Keywords:
Name View
INSTILADRIN View
BCG Refractory or Relapsed Superficial Bladder Cancer View
rAd-IFN View
Syn3 View
Intravesical View
transitional cell carcinoma of the bladder View
superficial non-muscle invasive tumor View
Interferon alpha2b View